Sulfamazone

DB13556

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 560.6
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Sulfamazone is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfamazone is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfamazone is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfamazone is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfamazone is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfamazone is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfamazone.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfamazone.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfamazone.
Cyclosporine The risk or severity of renal failure can be increased when Sulfamazone is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfamazone.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfamazone.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfamazone.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfamazone.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfamazone.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Sulfamazone.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfamazone.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfamazone.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfamazone.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Sulfamazone.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfamazone.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfamazone.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfamazone.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfamazone.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfamazone.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfamazone.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfamazone.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfamazone.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfamazone.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfamazone.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfamazone.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfamazone.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfamazone.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfamazone.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfamazone.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfamazone.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfamazone.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfamazone.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfamazone.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfamazone.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfamazone.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfamazone.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfamazone.
Insulin aspart The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfamazone.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfamazone.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Sulfamazone.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfamazone.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfamazone.
NN344 The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfamazone.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfamazone.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfamazone.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfamazone.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfamazone.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfamazone.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfamazone.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfamazone.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamazone.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamazone.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfamazone.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfamazone.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfamazone.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfamazone.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfamazone.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfamazone.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfamazone.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfamazone.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfamazone.
Insulin beef The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Sulfamazone is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfamazone.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfamazone.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Sulfamazone.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfamazone.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfamazone.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfamazone.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfamazone.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfamazone.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfamazone.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfamazone.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfamazone.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfamazone.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfamazone.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfamazone.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfamazone.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfamazone.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfamazone.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfamazone.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfamazone.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfamazone.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfamazone.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul